Exploratory phase 2 efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse

D. Armstrong; A. Bicher; R. Coleman; D. Gibbon; D.  Glenn; N. Senzer; A. Schneeweiss; RHM Verheijen; A. White; S. Weil

Exploratory phase 2 efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse

D. Armstrong
, A. Bicher
, R. Coleman
, D. Gibbon
, D. Glenn
, N. Senzer
, A. Schneeweiss
, RHM Verheijen
, A. White
, S. Weil

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2008
Event	ASCO - , United Kingdom Duration: 5 Mar 2008 → …

Conference

Conference	ASCO
Country/Territory	United Kingdom
Period	5/03/08 → …

Cite this

@conference{ffe88c785bf841a48150305dccc824f4,

title = "Exploratory phase 2 efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse",

author = "D. Armstrong and A. Bicher and R. Coleman and D. Gibbon and D. Glenn and N. Senzer and A. Schneeweiss and RHM Verheijen and A. White and S. Weil",

year = "2008",

language = "English",

note = "ASCO ; Conference date: 05-03-2008",

}

TY - CONF

T1 - Exploratory phase 2 efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse

AU - Armstrong, D.

AU - Bicher, A.

AU - Coleman, R.

AU - Gibbon, D.

AU - Glenn, D.

AU - Senzer, N.

AU - Schneeweiss, A.

AU - Verheijen, RHM

AU - White, A.

AU - Weil, S.

PY - 2008

Y1 - 2008

M3 - Abstract

T2 - ASCO

Y2 - 5 March 2008

ER -